EQUITY RESEARCH MEMO

Midwest Clinical Research

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)60/100

Midwest Clinical Research (MCR), operating as Ohio Clinical Trials (OCT), is a well-established clinical research organization (CRO) and dedicated research site based in Dayton, Ohio. Founded in 1994, MCR provides comprehensive Phase I-III clinical trial services to pharmaceutical sponsors and CROs, with a strong specialization in early-phase and complex studies. The company operates a large, fully-equipped inpatient facility capable of housing participants for extended periods, positioning it as a key resource for trials requiring intensive monitoring and long-duration stays. With over 25 years of experience in the midwest clinical research landscape, MCR has built a reputation for reliable, high-quality trial execution, particularly in therapeutic areas requiring close patient management.

Upcoming Catalysts (preview)

  • Q3 2026Major PhRMA Company Phase I Contract Win70% success
  • Q1 2027Inpatient Facility Capacity Expansion65% success
  • Q4 2026Strategic Partnership for Complex Oncology Studies60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)